Evidence map›Paper›PMID 29155856›Full record

ArticlePloS one2017

Treatment with solubilized Silk-Derived Protein (SDP) enhances rabbit corneal epithelial wound healing.

Waleed Abdel-Naby, Brigette Cole, Aihong Liu, Jingbo Liu, Pengxia Wan, Ryan Schreiner, David W Infanger, Nicholas B Paulson, Brian D Lawrence, Mark I Rosenblatt

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06840990 (Ophthalmic Solution in Corneal Re-epithelization), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06840990 completednot on this mapstarted 2023, after this paper: background citation

Ophthalmic Solution in Corneal Re-epithelization

Typeobservational_patient_registrySponsorD&V FARMA srlRan2023 to 2024Enrolled20ConditionsCorneal Epithelial Wound HealingArmsCXC-SP, CTRL
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 31 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Silk Fibroin in Wound Healing Process.Advances in experimental medicine and biology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Waleed Abdel-NabyDepartment of Biomedical Engineering, Cornell University, Ithaca, New York, United States of America.ORCID http://orcid.org/0000-0002-3664-2086
Brigette ColeDepartment of Ophthalmology, Weill Cornell Medical College, New York, New York, United States of America.
Aihong LiuDepartment of Ophthalmology, Weill Cornell Medical College, New York, New York, United States of America.
Jingbo LiuDepartment of Ophthalmology, Weill Cornell Medical College, New York, New York, United States of America.
Pengxia WanDepartment of Ophthalmology, Weill Cornell Medical College, New York, New York, United States of America.
Ryan SchreinerDepartment of Ophthalmology, Weill Cornell Medical College, New York, New York, United States of America.
David W InfangerDepartment of Research, Silk Technologies, Ltd., Plymouth, Minnesota, United States of America.
Nicholas B PaulsonDepartment of Research, Silk Technologies, Ltd., Plymouth, Minnesota, United States of America.
Brian D LawrenceDepartment of Research, Silk Technologies, Ltd., Plymouth, Minnesota, United States of America.
Mark I RosenblattDepartment of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, Illinois, United States of America.
Cornell University · USSilk Technologies (United States) · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a significant clinical need to improve current therapeutic approaches to treat ocular surface injuries and disease, which affect hundreds of millions of people annually worldwide. The work presented here demonstrates that the presence of Silk-Derived Protein (SDP) on the healing rabbit corneal surface, administered in an eye drop formulation, corresponds with an enhanced epithelial wound healing profile. Rabbit corneas were denuded of their epithelial surface, and then treated for 72-hours with either PBS or PBS containing 5 or 20 mg/mL SDP in solution four times per day. Post-injury treatment with SDP formulations was found to accelerate the acute healing phase of the injured rabbit corneal epithelium. In addition, the use of SDP corresponded with an enhanced tissue healing profile through the formation of a multi-layered epithelial surface with increased tight junction formation. Additional biological effects were also revealed that included increased epithelial proliferation, and increased focal adhesion formation with a corresponding reduction in the presence of MMP-9 enzyme. These in vivo findings demonstrate for the first time that the presence of SDP on the injured ocular surface may aid to improve various steps of rabbit corneal wound healing, and provides evidence that SDP may have applicability as an ingredient in therapeutic ophthalmic formulations.

Indexed as

AnimalsBiomarkersBombyxCell MovementCell ProliferationCorneal InjuriesEpithelial CellsEpithelium, CornealFibroinsFocal AdhesionsGene ExpressionMatrix Metalloproteinase 9Ophthalmic SolutionsRabbitsWound HealingZonula Occludens-1 ProteinBiomarkersFibroinsfibroin, silkwormMatrix Metalloproteinase 9Ophthalmic SolutionsZonula Occludens-1 Protein

Identifiers

PMID29155856
PMCPMC5695843
OpenAlexW2769311693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.